These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Fluid state and blood pressure control: no differences between APD and CAPD. Cnossen TT, Konings CJ, Fagel WJ, van der Sande FM, van Geel K, Leunissen KM, Kooman JP. ASAIO J; 2012; 58(2):132-6. PubMed ID: 22370683 [Abstract] [Full Text] [Related]
32. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients? Bazzato G, Coli U, Landini S, Fracasso A, Morachiello P, Righetto F, Scanferla F, Onesti G. Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936 [No Abstract] [Full Text] [Related]
37. [Treatment by continuous ambulatory peritoneal dialysis for chronic renal insufficiency in the diabetic]. Rottembourg J, Issad B, Allouache M, Diab R, Hamani A, Jacobs C. Nephrologie; 1995 Nov 08; 16(1):111-21. PubMed ID: 7700411 [Abstract] [Full Text] [Related]
38. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests. Thorp ML, Wilks TS. Am J Kidney Dis; 2004 May 08; 43(5):927-9. PubMed ID: 15112185 [Abstract] [Full Text] [Related]
39. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration. Scarpioni L, Ballocchi S, Castelli A, Scarpioni R. Perit Dial Int; 1994 May 08; 14(2):127-31. PubMed ID: 8043664 [Abstract] [Full Text] [Related]